Condition: Exocrine Pancreatic Insufficiency · Sponsor: Ohio State University
This study aims to evaluate if a 6-month course of pancrelipase (CREON) treatment improves symptoms of exocrine pancreatic insufficiency (EPI) after an attack of acute pancreatitis. Diagnosis of EPI is measured by a fecal elastase value of \<200, and patients must have a qualifying symptom burden based on the EPI symptom tracker survey. Blood and stool will be analyzed as part of this study, and other surveys of health status will be used to track improvement of symptoms.
This description comes directly from the study's public registry record.
Zoe Krebs · 614-685-3619 · zoe.krebs@osumc.edu
Always discuss trial participation with your own doctor first.
| University of Southern California | Los Angeles, California, United States | Recruiting |
| University of Illinois Chicago | Chicago, Illinois, United States | Recruiting |
| University of Minnesota | Minneapolis, Minnesota, United States | Not Yet Recruiting |
| New York University Langone Medical Center | New York, New York, United States | Withdrawn |
| The Ohio State University | Columbus, Ohio, United States | Recruiting |
| University of Pittsburgh | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06477159